NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品名：Promethazine 50mg/ml 1ml SDA - Box/25生产商：WEST-WARDProduct Code: CP-07-0149635NDC Code: 0641-1496-35
产品名称：SULFAMETHOXAZOLE AND TRIMETHOPRIM上市时间：07/06/2022NDA/ANDA/BLA:74650持证商：AKORNNDC:67296-1502-1,67296-1502-2,50383-824-16,50383-823-16,50383-824-21说明书：批准信：
产品名称：IPRATROPIUM BROMIDE上市时间：08/16/2022NDA/ANDA/BLA:215105持证商：AMNEALNDC:69238-2017-2说明书：批准信：
产品名称：SULFAMETHOPRIM上市时间：09/22/2022NDA/ANDA/BLA:70022持证商：NOVEL LABS INCNDC:说明书：批准信：
产品名称：ZOLEDRONIC ACID上市时间：11/02/2022NDA/ANDA/BLA:202828持证商：INFORLIFENDC:25021-830-82说明书：批准信：
产品名称：ATOMOXETINE HYDROCHLORIDE上市时间：12/20/2022NDA/ANDA/BLA:79016持证商：AUROBINDO PHARMANDC:64980-376-10,71335-2162-1,64980-377-10,65862-241-30,65862-242-30,65862-244-30,35573-415-30,35573-416-30,35573-417-30,35573-418-30,35573-419-30,35573-420-30,35573-421-30,65862-239-22,65862-238-22,65862-243-05,50090...
产品名称：LENALIDOMIDE上市时间：02/08/2023NDA/ANDA/BLA:211846持证商：SUN PHARMNDC:63304-042-01,63304-042-27,63304-043-01,63304-043-27,63304-044-01,63304-044-22,63304-046-01,63304-046-22,63304-041-01,63304-041-27,63304-045-01,63304-045-22说明书：批准信：
产品名称：TERIFLUNOMIDE上市时间：03/07/2023NDA/ANDA/BLA:209710持证商：SANDOZ INCNDC:0781-5747-31,0781-5755-31说明书：批准信：
产品名称：PREGABALIN上市时间：03/24/2023NDA/ANDA/BLA:214322持证商：CHANGZHOU PHARMNDC:27808-235-01,27808-236-01,27808-237-01,27808-238-01,27808-239-01,27808-240-01,27808-241-01说明书：批准信：
产品名称：CLOFARABINE上市时间：04/18/2023NDA/ANDA/BLA:207831持证商：GLAND PHARMA LTDNDC:72266-108-01,68083-386-01说明书：批准信：
药品名：ZEMDRNDC：71045-010-02 活性物质：PLAZOMICIN剂量：50MG/ML剂型：INJECTABLE市场状态：PrescriptionTE代码：NoneRLD：TBDRS：No适应症：Urinary Tract Infection持证商：Achaogen, Inc.持证商地址：South San Francisco, CA 94080上市时间：06/25/2018申请号：NDA 210303批准信文件：PDF说明书：PDF-------------------------------------------------------------------------...
